Results for the substance letermovir

Letermovir is an antiviral medication used to prevent cytomegalovirus (CMV) infection in patients who have undergone hematopoietic stem cell transplantation. It works by inhibiting the CMV terminase complex, preventing the virus from replicating.

The medication is administered orally or intravenously, usually once daily, and is used for a limited period as directed by a doctor.

Side effects may include nausea, diarrhea, headaches, or fatigue. In rare cases, severe allergic reactions or liver function impairment may occur.

Patients should inform their doctor about any other medications they are taking and strictly follow the administration instructions. Pregnant or breastfeeding women should consult a specialist before use.